Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Outcomes of patients with chronic myeloid leukemia receiving second-line therapy after failure of frontline second-generation tyrosine kinase inhibitor

Fadi Haddad, Hagop Kantarjian, Sara Dellasala, Ghayas Issa, Tapan Kadia, Jayastu Senapati, Rita Khouri, Nicholas Short, Courtney DiNardo, Nitin Jain, Hussein Abbas, Kelly Chien, Anwesha Ray, Naveen Pemmaraju, Farhad Ravandi, Guillermo Garcia-Manero, Koji Sasaki, Elias Jabbour

Blood (2025) 146 (Supplement 1): 5564.

https://doi.org/10.1182/blood-2025-5564

Published: 2025

Journal Articles

Epigenetic reactivation of a tumor suppressor program in AML.

Eric Wang, Cuijuan Han, Alexander Arnuk, Iannis Aifantis, Hussein Abbas, Aristotelis Tsirigos, Sadik Karma, Sakthi Harini Rajendran

Blood (2025) 146 (Supplement 1): 5000.

https://doi.org/10.1182/blood-2025-5000

Published: 2025

Journal Articles

Integrative proteomics and machine learning identify subtype- and symptom-associated signatures in systemic mastocytosis

Wei Xiao, Annie Hoai Nguyen, Ivo Veletic, Taghi Manshouri, Naveen Pemmaraju, Lucia Masarova, Prithviraj Bose, Hussein Abbas

Blood (2025) 146 (Supplement 1): 3758.

https://doi.org/10.1182/blood-2025-3758

Published: 2025

Journal Articles

Overcoming barriers to clinical trial enrollment among adolescents and young adults with acute myeloid leukemia: Insights from a large academic cancer center

Blood (2025) 146 (Supplement 1): 4613.

https://doi.org/10.1182/blood-2025-4613

Published: 2025

Journal Articles

Hnrnpk haploinsufficiency in del(9q) Acute Myeloid Leukemia reveals targetable vulnerabilities

Sean Post, Oscar Benitez, Ashley Rodriguez, Marisa Aitken, Prerna Malaney, Miguel Gallardo, Hussein Abbas

Blood (2025) 146 (Supplement 1): 5028.

https://doi.org/10.1182/blood-2025-5028

Published: 2025

Journal Articles

A blood-based protein signature adds to genomic prognostication of survival in TP53-mutated Acute Myeloid Leukemia

Sara Nofal, Jennifer Marvin-Peek, Sanam Loghavi, Jayastu Senapati, Bofei Wang, Fadi Haddad, Nicholas Short, Naval Daver, Ghayas Issa, Koji Sasaki, Gautam Borthakur, Tapan Kadia, Courtney DiNardo, Farhad Ravandi, Guillermo Garcia-Manero, Ehsan Irajizad, Hussein Abbas

Blood (2025) 146 (Supplement 1): 3503.

https://doi.org/10.1182/blood-2025-3503

Published: 2025

Journal Articles

Pre-malignant extracellular matrix drives leukemia transformation through reprogramming of pre-leukemic stem cells

Alvaro Cuesta-Dominguez, Ioanna Mosialou, Ziwei Chen, Abdullah Ali, Brygida Bisikirska, Rossella Labella, Diana Kotini, Malgorzata Olszewska, Hager Mansour, Stephanie Braunstein, Junfei Zhao, Aaron Viny, Hussein Abbas, Raul Rabadan, Eirini Papapetrou, Azra Raza, Stavroula Kousteni

Blood (2025) 146 (Supplement 1): 3187.

https://doi.org/10.1182/blood-2025-3187

Published: 2025

Journal Articles

Characteristics and outcomes for patients with concomitant myeloproliferative neoplasms (MPN) and autoimmune disorders

Blood (2025) 146 (Supplement 1): 2037.

https://doi.org/10.1182/blood-2025-2037

Published: 2025

Journal Articles

Clinicopathological characteristics and survival outcomes in adults with acute megakaryoblastic leukemia

Vanthana Bharathi, Alexandre Bazinet, Alex Bataller, Naval Daver, Courtney DiNardo, Hussein Abbas, Ian Bouligny, Gautam Borthakur, Fadi Haddad, Naveen Pemmaraju, Steven Kornblau, Wei-Ying Jen, Nicholas Short, Andres Quesada, Guillermo Garcia-Manero, Farhad Ravandi, Tapan Kadia

Blood (2025) 146 (Supplement 1): 3405.

https://doi.org/10.1182/blood-2025-3405

Published: 2025

Journal Articles

Treatment intensity may alter the prognostic impact of baseline co-mutations in newly diagnosed FLT3-ITD AML treated with FLT3 inhibitor-based therapy

Sankalp Arora, Jayastu Senapati, Nicholas Short, Musa Yilmaz, Sanam Loghavi, Tapan Kadia, Courtney DiNardo, Gautam Borthakur, Joseph Jabbour, Hannah Goulart, Ghayas Issa, Naveen Pemmaraju, Wei-Ying Jen, Hussein Abbas, Michael Andreeff, Hagop Kantarjian, Guillermo Garcia-Manero, Farhad Ravandi, Naval Daver

Blood (2025) 146 (Supplement 1): 3397.

https://doi.org/10.1182/blood-2025-3397

Published: 2025

Journal Articles

Ferroptosis activates NK and CAR T cell-mediated anti-tumor immunity in Acute Myeloid Leukemia

Saurabh Kumar Gupta, Kazuharu Kamachi, Liang Zhang, Ran Zhao, Babita Kaundal, Jiangxing LV, Li Li, Venkata Lokesh Battula, Xufeng Chen, Hussein Abbas, Michael Andreeff, Jo Ishizawa

Blood (2025) 146 (Supplement 1): 1496.

https://doi.org/10.1182/blood-2025-1496

Published: 2025

Journal Articles

Impact of NPM1 co-mutation on outcomes in RAS-mutated Acute Myeloid Leukemia

Fnu Amritpal Singh, Alex Bataller, Alexandre Bazinet, Gautam Borthakur, Courtney DiNardo, Naval Daver, Guillermo Montalban-Bravo, Nicholas Short, Wei-Ying Jen, Ghayas Issa, Hussein Abbas, Sanam Loghavi, Guillermo Garcia-Manero, Farhad Ravandi, Hagop Kantarjian, Tapan Kadia

Blood (2025) 146 (Supplement 1): 7029.

https://doi.org/10.1182/blood-2025-7029

Published: 2025

Journal Articles

Azacitidine (AZA) with Nivolumab (Nivo), and AZA with Nivo + Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Prospective, Phase 2 Study

Blood (2019) 134 (Supplement_1): 830.

https://doi.org/10.1182/blood-2019-131494

Published: 2019

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Outcomes of patients with chronic myeloid leukemia receiving second-line therapy after failure of frontline second-generation tyrosine kinase inhibitor

Epigenetic reactivation of a tumor suppressor program in AML.

Integrative proteomics and machine learning identify subtype- and symptom-associated signatures in systemic mastocytosis

Overcoming barriers to clinical trial enrollment among adolescents and young adults with acute myeloid leukemia: Insights from a large academic cancer center

Hnrnpk haploinsufficiency in del(9q) Acute Myeloid Leukemia reveals targetable vulnerabilities

A blood-based protein signature adds to genomic prognostication of survival in TP53-mutated Acute Myeloid Leukemia

Pre-malignant extracellular matrix drives leukemia transformation through reprogramming of pre-leukemic stem cells

Characteristics and outcomes for patients with concomitant myeloproliferative neoplasms (MPN) and autoimmune disorders

Clinicopathological characteristics and survival outcomes in adults with acute megakaryoblastic leukemia

Treatment intensity may alter the prognostic impact of baseline co-mutations in newly diagnosed FLT3-ITD AML treated with FLT3 inhibitor-based therapy

Ferroptosis activates NK and CAR T cell-mediated anti-tumor immunity in Acute Myeloid Leukemia

Impact of NPM1 co-mutation on outcomes in RAS-mutated Acute Myeloid Leukemia

Azacitidine (AZA) with Nivolumab (Nivo), and AZA with Nivo + Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Prospective, Phase 2 Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only